Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Risk of serious bacterial infection: treatment with anti-TNF versus methotrexate

Nature Clinical Practice Rheumatology volume 3, pages 546–547 (2007)Cite this article

boxed-textCurtis JF et al. (2007) Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists. Arthritis Rheum 56: 1125–1133

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Thomas E et al. (2003) National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 30: 958–965

    PubMed  Google Scholar 

  2. Bongartz T et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295: 2275–2285

    Article  CAS  Google Scholar 

  3. Listing J et al. (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52: 3403–3412

    Article  CAS  Google Scholar 

  4. Dixon WG et al. (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54: 2368–2376

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. A Zink is Professor of Epidemiology at the Department of Rheumatology, Charité Medical School and Head of the Epidemiology Unit at the Epidemiology Unit of the German Rheumatism Research Centre, and J Listing is Senior Statistician at the Epidemiology Unit of the German Rheumatism Research Centre, Berlin, Germany.,

    Angela Zink & Joachim Listing

Authors
  1. Angela Zink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joachim Listing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angela Zink.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zink, A., Listing, J. Risk of serious bacterial infection: treatment with anti-TNF versus methotrexate. Nat Rev Rheumatol 3, 546–547 (2007). https://doi.org/10.1038/ncprheum0594

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0594

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing